Director at Abbott (NYSE: ABT) receives stock equivalent unit award

Rhea-AI Filing Summary

ABBOTT LABORATORIES director Michael F. Roman received a grant of 367 stock equivalent units on Abbott shares as part of his director compensation. These units are credited to a stock equivalent unit account and are generally paid in cash at about age 65 or upon retirement from the board. Following this award, his balance totals 6,283 stock equivalent units, which earn the same return as if the underlying fees were invested in Abbott common shares, including units acquired through a dividend reinvestment feature.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Roman Michael F

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Equivalent Units	367	$102.67	$38K

Holdings After Transaction: Stock Equivalent Units — 6,283 shares (Direct)

Footnotes (1)

1. Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Key Figures

Stock equivalent units granted: 367 units Reference price per unit: $102.67 per unit Total units after grant: 6,283 units +1 more

4 metrics

Stock equivalent units granted 367 units Director grant on March 31, 2026

Reference price per unit $102.67 per unit Stock equivalent unit grant value reference

Total units after grant 6,283 units Stock equivalent units held after reported transaction

Underlying common shares per unit 1 share per unit 367 underlying common shares for 367 units

Key Terms

Stock Equivalent Units, dividend reinvestment feature, director fees

3 terms

Stock Equivalent Units financial

"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board."

Stock equivalent units are financial claims or instruments that are treated as if they were actual shares for purposes like calculating ownership, dilution, and earnings per share. Think of them as promises or placeholders for future slices of company pie—options, restricted units, or convertible securities—that don’t yet sit on the table but will reduce each existing slice when converted. Investors track them because they change how much of a company each share really represents and can affect valuation and voting power.

dividend reinvestment feature financial

"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."

director fees financial

"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roman Michael F

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Equivalent Units	(1)	03/31/2026		A		367		(1)	(1)	Common Shares	367	$102.67	6,283(2)	D

Explanation of Responses:

1. Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

	/s/ Michael F. Roman by Jessica H. Paik, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Abbott Laboratories (ABT) director Michael F. Roman report in this Form 4?

Michael F. Roman reported receiving 367 stock equivalent units tied to Abbott Laboratories shares as director compensation. These units are credited to an account, track Abbott’s share returns, and increase his total balance to 6,283 stock equivalent units.

Are Michael F. Roman’s 367 stock equivalent units in ABT an open-market purchase or sale?

The 367 stock equivalent units are a grant classified as a compensation-related acquisition, not an open-market buy or sell. They represent director fees credited in unit form rather than a discretionary market transaction in Abbott Laboratories common stock.

How and when are Abbott (ABT) director stock equivalent units paid out?

The stock equivalent units are credited to a special account and generally paid in cash at about age 65 or upon retirement from the board. Until then, the units earn the same return as if invested directly in Abbott Laboratories shares.

How many stock equivalent units in Abbott (ABT) does Michael F. Roman hold after this filing?

After receiving 367 additional stock equivalent units, Michael F. Roman’s reported balance is 6,283 units. These units mirror the performance of Abbott Laboratories common shares and include amounts accumulated through a dividend reinvestment feature.

Do Abbott (ABT) stock equivalent units for directors include dividend reinvestment?

Yes. The reported balance of 6,283 stock equivalent units includes units acquired through a dividend reinvestment feature. This means distributions associated with Abbott Laboratories shares are effectively reinvested into additional stock equivalent units in the account.